| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC3190 |
| Trial ID | NCT05554575 |
| Disease | T Cell Lymphoblastic Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BT-007 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL |
| Year | 2022 |
| Country | China |
| Company sponsor | Bioceltech Therapeutics, Ltd. |
| Other ID(s) | BT-LBL-007-v2 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||